User:Mr. Ibrahem/Ropeginterferon alfa-2b

Ropeginterferon alfa-2b, sold under the brand name Besremi, is a medication used to treat polycythemia vera. It is used in those with a normal spleen. It is given by injection under the skin.

Common side effects include low white blood cells, low platelets, muscle and joint pain, tiredness, flu-like symptoms and liver inflammation. Other side effects may include allergic reactions, infections, pancreatitis, eye problems, and kidney problems. It should not be used in people with liver problems or severe depression. Use during pregnancy may harm the baby. It is a type of interferon.

Ropeginterferon alfa-2b was approved for medical use in Europe in 2019 and the United States in 2021. In the United Kingdom it costs the NHS about £1,800 for 250 mcg as of 2021. This amount in the United States is about 3,600 USD as of 2022.